Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Stress Management and Multiple Sclerosis: A Randomized Controlled Trial.
Amiloride HCl
Axonal conduction and injury in multiple sclerosis: the role of sodium channels.
Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats.
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally.
Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial.
Comparing the biological impact of glatiramer acetate with the biological impact of a generic.
Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis.
Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions.
Teva Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE(R) Patent
Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study.
Pregnancy outcomes in female patients and partners of male patients in the teriflunomide clinical development program.
Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair.
Demyelination affects temporal aspects of perception: An optic neuritis study.
RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis.
Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis.
Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis.
Lipocalin 2 is present in the EAE brain and is modulated by natalizumab.
Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration.
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
Poor sleep in patients with multiple sclerosis.
Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor.
The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population.

Pages